Product
Active Comparator
Aliases
Seasonal influenza vaccine
14 clinical trials
17 indications
Indication
Diabetes MellitusIndication
Type 2Indication
Clostridioides difficile infectionIndication
COVID-19Indication
Seasonal InfluenzaIndication
Adverse Reaction to ImmunizationIndication
Adverse Vaccine ReactionIndication
Dry Eye SyndromeIndication
Infectious DiseaseIndication
PainIndication
PostoperativeIndication
Esophageal cancerIndication
Colorectal cancerIndication
Colorectal CancerIndication
Clear Cell Renal Cell CarcinomaIndication
Renal Cell CarcinomaIndication
Stage IV Renal Cell Cancer AJCC v8Clinical trial
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry DataStatus: , Estimated PCD: 2024-12-31
Clinical trial
A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile InfectionStatus: Active (not recruiting), Estimated PCD: 2024-02-01
Clinical trial
A Phase IIb/3 Randomized, Multi-Center, Placebo-Controlled Noninferiority Study to Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine (IIBR-100) in Adults Compared to an Approved COVID-19 VaccineStatus: Withdrawn, Estimated PCD: 2021-12-31
Clinical trial
Phase 1/2, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1020 and mRNA-1030 Candidate Seasonal Influenza Vaccines in Healthy AdultsStatus: Completed, Estimated PCD: 2022-11-22
Clinical trial
A Phase III, Observer-Blind, Randomized, Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children Aged 12-17 Years in IndonesiaStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled Clinical Trial Evaluating the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2023-01-24
Clinical trial
A PHASE 1/2 STUDY TO ASSESS THE SAFETY AND IMMUNOGENICITY OF A BROADLY PROTECTIVE mRNA VACCINE JCXH-221 AGAINST SARS-CoV-2 INFECTION AND DISEASESStatus: Recruiting, Estimated PCD: 2024-09-06
Clinical trial
A Phase 1/2, Randomized, Stratified, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults 18 Years and OlderStatus: Completed, Estimated PCD: 2022-09-27
Clinical trial
A Randomized, Double-Blinded, Active Controlled COVID-19 Study to Evaluate The Safety, Tolerability, And Immunogenicity Of Different Doses Of VLA2001 Vaccine, In Children (≥2 To <12 Years)Status: Withdrawn, Estimated PCD: 2023-07-31
Clinical trial
Immunogenicity & Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Bio Farma) Adjuvanted With Alum+CpG 1018 Compared to Registered Covid-19 Vaccine (Covovax - Protein Subunit Vaccine) in Healthy Populations Aged 18 Years and Above in Indonesia (Phase III)Status: Completed, Estimated PCD: 2022-08-05
Clinical trial
Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)Status: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer vs Cross Therapy.Status: Not yet recruiting, Estimated PCD: 2028-03-01
Clinical trial
An Open-label, Multi-centered, Two-stage Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine in the First Line Treatment of Advanced mCRC Patients Unfit for Intense TherapyStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)Status: Recruiting, Estimated PCD: 2033-07-01